Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-05

Clinical Trial Results: Abaloparatide Before Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating abaloparatide before knee replacement surgery, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abaloparatide (abaloparatide)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Osteoporosis, Arthroplasties, Knee Replacement | Phase 4 | Status: COMPLETED | Results posted: 2026-06-05